news roundup
Clinerion and Sigmasoft have entered into a partnership that will aim to bring access to international clinical studies for patients, physicians, and healthcare institutions in Greece and Cyprus.
Advertisement Operational Challenges in Resourcing and
Executing Seasonal Infectious Diseases Studies
North America: Thursday, June 13, 2019 at 11am EDT | 10am CDT | 8am PDT
Register now |
OmniComm has launched TrialOne Express, an eClinical solution for Phase I clinic automation. TrialOne Express provides preset configurations that will enable researchers with limited resources to automate their facilities and quickly launch clinical studies.
Advertisement Operational Challenges in Resourcing and
Executing Seasonal Infectious Diseases Studies
Europe: Thursday, June 6, 2019 at 3pm BST | 4pm CEST
Register now |
Analgesic Solutions provides knowledge-based solutions that inform the conduct of clinical trials in which the measurement of pain is an endpoint or significant component.
Advertisement Technology: Friend vs Foe - Considerations for Practical Execution of a Risk-Based Monitoring Strategy
Tuesday, April 23, 2019 at 11am EDT | 10am CDT | 4pm BST | 5pm CEST
Register now |
Articles
In this article, The Michael J. Fox Foundation for Parkinson's Research (MJFF) explores how one study team implemented a multimodal recruitment strategy to meet their target enrollment six months ahead of schedule.
Advertisement RBM Case Studies: How Artificial Intelligence and Machine Learning with Advanced Analytics are driving new levels of patient safety and study quality
On Demand
Learn More |
Blog Posts
Columnist Peter O'Donnell provides a timeline of events that found patient organizations across Europe saying that bluebird bio's therapy for transfusion-dependent beta-thalassaemia (TDT) called Zynteglo announcing it was approved, when this was not the case.
The need to involve patient advocacy groups as a way of gaining patient insight is a growing movement and one that is shifting from a transactional, less-involved relationship to one that is more strategic.
|